Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.8%

1 terminated out of 21 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

33%

7 trials in Phase 3/4

Results Transparency

60%

9 of 15 completed with results

Key Signals

9 with results94% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (3)
Early P 1 (1)
P 1 (2)
P 2 (7)
P 3 (7)

Trial Status

Completed15
Withdrawn2
Unknown2
Recruiting1
Terminated1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT05937672Phase 3Recruiting

Cold Atmospheric Plasma Device Extension Study

NCT05680181CompletedPrimary

Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin

NCT05536882Phase 3WithdrawnPrimary

MC RCT - BPO vs Adapalene

NCT05897112Phase 1CompletedPrimary

Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum

NCT03436615Phase 2CompletedPrimary

A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum

NCT03927703Phase 3CompletedPrimary

A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC

NCT04535531Phase 3CompletedPrimary

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study

NCT03927716Phase 3CompletedPrimary

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

NCT05634460Phase 1CompletedPrimary

Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagiosum

NCT02759900Not ApplicableUnknown

Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

NCT03336372Early Phase 1WithdrawnPrimary

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

NCT03377790Phase 3CompletedPrimary

Cantharidin Application in Molluscum Patients-1

NCT03377803Phase 3CompletedPrimary

Cantharidin Application in Molluscum Patients

NCT03186378Phase 2CompletedPrimary

Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.

NCT04476186Not ApplicableUnknownPrimary

The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children

NCT02902822Not ApplicableCompleted

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

NCT02024581Phase 2TerminatedPrimary

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum

NCT03017846Phase 2CompletedPrimary

Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2

NCT03077750Phase 2CompletedPrimary

A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum

NCT02665260Phase 2CompletedPrimary

Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum

Scroll to load more

Research Network

Activity Timeline